Herpes simplex virus G47Δ-mIL12 has been noted in inducing anti-tumor immunity and the triple combination of G47Δ-mIL12, anti-PD-1 and anti-CTLA-4 extended survival of a GBM mouse model (Saha et al., 2017). This evidence concerns the gene CTLA4 and glioblastoma.